WallStreetZenWallStreetZen

NASDAQ: VTGN
Vistagen Therapeutics Inc Stock Ownership - Who owns Vistagen Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vistagen Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Reid G. AdlerChief Legal Officer2026-06-3036,818$0.19
$7.07kBuy
Shawn SinghPresident and CEO2026-06-3036,818$0.19
$7.07kBuy
Nick B. TresslerChief Financial Officer2026-06-3011,712$0.19
$2.25kBuy
Joshua S. PrinceChief Operating Officer2025-12-314,386$0.56
$2.47kBuy

1 of 1

VTGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTGN insiders and whales buy or sell their stock.

VTGN Shareholders

What type of owners hold Vistagen Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Venrock Healthcare Capital Partners II LP46.50%20,637,286$5.04MInsider
Holding Co Cato7.46%3,310,836$807.84kInsider
Platinum Long Term Growth VII LLC3.51%1,558,862$380.36kInsider
Commodore Capital LP1.80%799,244$195.02kInsider
Allen Easley Cato1.02%452,621$110.44kInsider
Jerry B. Gin0.90%400,000$97.60kInsider
A. Franklin Rice0.39%174,046$42.47kInsider
Shawn Singh0.28%122,830$29.97kInsider
H. Ralph Snodgrass0.22%98,859$24.12kInsider
Reid G. Adler0.14%60,868$14.85kInsider

1 of 3

VTGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTGN0.03%62.54%Net BuyingNet Buying
TOVX0.00%0.54%
ASBP0.00%100.00%
MBRX0.00%32.51%Net SellingNet Selling
PBM0.00%100.00%
View Top Biotech Stocks

Vistagen Therapeutics Stock Ownership FAQ

Who owns Vistagen Therapeutics?

Vistagen Therapeutics (NASDAQ: VTGN) is owned by 0.03% institutional shareholders, 62.54% Vistagen Therapeutics insiders, and 37.43% retail investors. Venrock Healthcare Capital Partners II LP is the largest individual Vistagen Therapeutics shareholder, owning 20.64M shares representing 46.50% of the company. Venrock Healthcare Capital Partners II LP's Vistagen Therapeutics shares are currently valued at $5.04M.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.